Gov. Mike DeWine (R) on Thursday announced that he is asking the Ohio Board of Pharmacy to reverse its rule banning the selling or dispensing of hydroxychloroquine and the related drug chloroquine for the treatment of COVID-19.
In a statement, DeWine said he agrees with the statement from Dr. Steven Hahn, Commissioner of the U.S. Food and Drug Administration (FDA), that the decision about prescribing hydroxychloroquine to treat COVID-19 should be between a doctor and a patient.
“The Board of Pharmacy and the State Medical Board of Ohio should revisit the issue, listen to the best medical science, and open the process up for comment and testimony from experts,” DeWine said in a statement released Thursday.
Hydroxychloroquine has been touted as a treatment and preventative for COVID-19 by President Donald Trump and others, such as Brazilian President Jair Bolsonaro.
However, emerging scientific evidence suggests the drug, which is approved for the treatment of malaria and other conditions like rheumatoid arthritis, is not effective against COVID-19 and could even cause serious side effects, according to the FDA.
Should people be taking hydroxychloroquine? –@savannahguthrie
— TODAY (@TODAYshow) July 30, 2020